← Back to Search

Barrier Film

Cavilon Advanced Skin Protectant for Incontinence Associated Dermatitis

N/A
Waitlist Available
Research Sponsored by Solventum US LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 21 days depending on length of hospitalization
Awards & highlights
No Placebo-Only Group

Summary

The purpose of the study is to evaluate the safety and efficacy of the investigational product (3M™ Cavilon™ Advanced High Endurance Skin Protectant) for the treatment of incontinence associated dermatitis.

Eligible Conditions
  • Incontinence Associated Dermatitis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 21 days depending on length of hospitalization
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 21 days depending on length of hospitalization for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Percent Change From Baseline to End of Study in Incontinence Associated Dermatitis (IAD) Scores
Secondary study objectives
Pain Scores During Incontinence Management
Prevention of IAD.
Re-epithelialization to a Category 1 or Lower

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Cavilon Advanced Skin ProtectantExperimental Treatment1 Intervention
Product applicator contains liquid barrier applied on buttocks/thighs with it drying rapidly to durable barrier film. It's applied 3x/per week.
Group II: ConvaTec Sensi-Care Protective BarrierActive Control1 Intervention
Marketed product applied following manufacturer's recommendation. The product is 15% zinc oxide with petrolatum.

Find a Location

Who is running the clinical trial?

Solventum US LLCLead Sponsor
50 Previous Clinical Trials
7,827 Total Patients Enrolled
3MIndustry Sponsor
158 Previous Clinical Trials
31,439 Total Patients Enrolled
3 Trials studying Incontinence Associated Dermatitis
611 Patients Enrolled for Incontinence Associated Dermatitis
Pat Parks, MDStudy Director3M
~4 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top